Price
Target price
€10.87
€10.87
-1.440%
-0.155
-1.440%
€22.78
26.04.24 / Tradegate
WKN: A2DT49 / Symbol: IOVA / Name: Iovance Biotherapeutics / Stock / Biotechnology & Medical Research / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Iovance Biotherapeutics Inc. Stock
We can see a decrease in the price for Iovance Biotherapeutics Inc.. Compared to yesterday it has lost -€0.155 (-1.440%).
Currently there is a rather positive sentiment for Iovance Biotherapeutics Inc. with 19 Buy predictions and 3 Sell predictions.
With a target price of 22 € there is potential for a 102.49% increase which would mean more than doubling the current price of 10.87 € for Iovance Biotherapeutics Inc..
So far the community has only identified positive things for Iovance Biotherapeutics Inc. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Iovance Biotherapeutics Inc. in the next few years
Pros
?
C******** o* t** e**********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Cons
?
S********** s********
?
B****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Iovance Biotherapeutics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Iovance Biotherapeutics Inc. | -1.440% | 2.211% | -16.359% | 119.362% | 39.152% | -60.289% | - |
| Novocure Ltd | 3.070% | 4.053% | -2.114% | -79.652% | -17.268% | -93.443% | - |
| Sage Therapeutics Inc. | -0.350% | 2.037% | -26.156% | -70.428% | -36.125% | -80.292% | - |
| Fibrogen Inc. | -0.330% | -11.959% | -58.142% | -94.914% | 10.000% | -94.708% | - |
Comments
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $32.00 price target on the stock.
Show more
Ratings data for IOVA provided by MarketBeat
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $19.00 to $21.00. They now have a "buy" rating on the stock.
Show more
Ratings data for IOVA provided by MarketBeat
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) had its price target raised by analysts at Barclays PLC from $18.00 to $22.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for IOVA provided by MarketBeat
